Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens

196Citations
Citations of this article
105Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study evaluated whether trimethoprim-sulfamethoxazole (TMP-SMX) is effective for treatment of uncomplicated urinary tract infections (UTIs) due to TMP-SMX-resistant (TMP-SMX-R) pathogens. Healthy nonpregnant premenopausal women with symptomatic lower UTI were assessed for the presence of pyuria and bacteriuria; if either was present, a urine sample was cultured and TMP-SMX was prescribed. Clinical and microbiologic cure was assessed at days 5-9 and 28-42 after cessation of therapy. For 71%, of patients, cultures grew TMP-SMX-susceptible (TMP-SMX-S) microorganisms, and for 29%, cultures grew TMP-SMX-R organisms. Escherichia coli remained the predominant bacteria in both groups of cultures. At visit 2, microbiological cure had been achieved in 86% of the patients in the TMP-SMX-S group and 42% of those in the TMP-SMX-R group. Similar differences were found at visit 3 by clinical evaluation. Treatment with TMP-SMX of uncomplicated UTI caused by TMP-SMX-R microorganisms results in microbiologic and clinical failure. In high-resistance areas, TMP-SMX should not be the empiric drug of choice for uncomplicated UTI.

References Powered by Scopus

Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women

1028Citations
N/AReaders
Get full text

Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women

485Citations
N/AReaders
Get full text

Trimethoprim and sulfonamide resistance

408Citations
N/AReaders
Get full text

Cited by Powered by Scopus

International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

2240Citations
N/AReaders
Get full text

Setting and revising antibacterial susceptibility breakpoints

448Citations
N/AReaders
Get full text

The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections

312Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Raz, R., Chazan, B., Kennes, Y., Colodner, R., Rottensterich, E., Dan, M., … Gvidolin, A. (2002). Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clinical Infectious Diseases, 34(9), 1165–1169. https://doi.org/10.1086/339812

Readers over time

‘10‘11‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘250481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 38

64%

Researcher 14

24%

Professor / Associate Prof. 5

8%

Lecturer / Post doc 2

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 29

59%

Agricultural and Biological Sciences 11

22%

Biochemistry, Genetics and Molecular Bi... 5

10%

Chemistry 4

8%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free
0